Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-02

Clinical Trial Update: Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of oral AC430 in healthy subjects; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AC430 (AC430)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED